Does THIOGUANINE ANHYDROUS Cause Second primary malignancy? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Second primary malignancy have been filed in association with THIOGUANINE ANHYDROUS. This represents 1.1% of all adverse event reports for THIOGUANINE ANHYDROUS.
13
Reports of Second primary malignancy with THIOGUANINE ANHYDROUS
1.1%
of all THIOGUANINE ANHYDROUS reports
9
Deaths
8
Hospitalizations
How Dangerous Is Second primary malignancy From THIOGUANINE ANHYDROUS?
Of the 13 reports, 9 (69.2%) resulted in death, 8 (61.5%) required hospitalization.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for THIOGUANINE ANHYDROUS. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does THIOGUANINE ANHYDROUS Cause?
Febrile neutropenia (191)
Off label use (98)
Venoocclusive liver disease (85)
Pancytopenia (74)
Pyrexia (72)
Drug ineffective (69)
Thrombocytopenia (63)
Anaemia (62)
Neutropenia (54)
Abdominal pain (53)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which THIOGUANINE ANHYDROUS Alternatives Have Lower Second primary malignancy Risk?
THIOGUANINE ANHYDROUS vs THIOPENTAL
THIOGUANINE ANHYDROUS vs THIORIDAZINE
THIOGUANINE ANHYDROUS vs THIOTEPA
THIOGUANINE ANHYDROUS vs THIOTHIXENE
THIOGUANINE ANHYDROUS vs THROMBIN